Vir Biotechnology
VIR
VIR
251 hedge funds and large institutions have $1.25B invested in Vir Biotechnology in 2026 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 117 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
17.18% more ownership
Funds ownership: 83.24% → 100.42% (+17%)
15% more funds holding
Funds holding: 218 → 251 (+33)
Holders
251
Holding in Top 10
6
Calls
$4.54M
Puts
$3.36M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$16M | |
| 3 | +$14M | |
| 4 |
Goldman Sachs
New York
|
+$13.4M |
| 5 |
BlackRock
New York
|
+$13.3M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$14.4M | |
| 3 | -$8.66M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$8.39M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.25M |
